SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-18-004769
Filing Date
2018-02-02
Accepted
2018-02-02 16:45:19
Documents
1
Group Members
CHARLES SERMONDENISE SCOTS-KNIGHT, PH.D.DR. ALASTAIR MCKINNONPHASE4 VENTURES III GENERAL PARTNER LTDPHASE4 VENTURES III GP LPPHASE4 VENTURES III LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A formsc13da.htm SC 13D/A 231762
  Complete submission text file 0001140361-18-004769.txt   233638
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Subject) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83386 | Film No.: 18571370
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address GREEN PARK HOUSE 15 STRATTON STREET LONDON X0 W1J 8LQ
Business Address GREEN PARK HOUSE 15 STRATTON STREET LONDON X0 W1J 8LQ 44 0 20 3036 0050
Phase4 Partners Ltd (Filed by) CIK: 0001600023 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A